Home » Stocks » HUGE

FSD Pharma Inc. (HUGE)

Stock Price: $1.70 USD 0.11 (6.92%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $1.69 -0.01 (-0.59%) May 7, 7:42 PM
Market Cap 60.69M
Revenue (ttm) n/a
Net Income (ttm) -24.94M
Shares Out 35.99M
EPS (ttm) -2.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $1.70
Previous Close $1.59
Change ($) 0.11
Change (%) 6.92%
Day's Open 1.65
Day's Range 1.62 - 1.70
Day's Volume 352,505
52-Week Range 1.28 - 14.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) has announced the appointment of Nathan Coyle, the company's corporate controller as its interim chief financial officer with immediate effect, following the dep...

4 days ago - Proactive Investors

TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") is pleased to announce the appointment of Nathan Coyle, the Company's Corporate Controller as...

4 days ago - Business Wire

TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") wishes to alert you to the events that have occurred since the Company filed its Management I...

6 days ago - Business Wire

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...

Other stocks mentioned: APHA, HEXO, KERN, PM, SNDL, TLRY, XXII ...
1 week ago - Schaeffers Research

Toronto, Ontario--(Newsfile Corp. - April 26, 2021) - On Monday, April 26, 2021, the group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K...

1 week ago - Newsfile Corp

TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") announces the filing of its Management Information Circular (the "Circular") and an accompany...

2 weeks ago - Business Wire

Focused on lead anti-inflammatory drug FSD-201 Launched Phase 2 study of drug known as micro PEA in December 2020 Developing drugs to treat gastrointestinal diseases in dogs and cats What FSD Pharma doe...

2 weeks ago - Proactive Investors

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...

Other stocks mentioned: CGC, GNLN, HEXO, IIPR, KERN, OGI, SNDL ...
3 weeks ago - Schaeffers Research

TORONTO, April 5, 2021 /PRNewswire/ - On Tuesday, March 30, 2021, Anthony Durkacz, a founding director and member of the group of concerned shareholders, which also includes founding shareholder Zeeshan...

1 month ago - PRNewsWire

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...

Other stocks mentioned: CRBP, GNLN, IIPR, NTEC, OGI
1 month ago - Schaeffers Research

TORONTO--(BUSINESS WIRE)---- $HUGE #FSD--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced that it has commenced an application in the Ontario Superior Court see...

1 month ago - Business Wire

bluebird bio, Inc. (NASDAQ: BLUE), Onconova Therapeutics, Inc. (NASDAQ: ONTX), FSD Pharma Inc. (NASDAQ: HUGE) and Immatics N.V. (NASDAQ: IMTX) are among the biggest biopharma movers in Wednesday's session.

Other stocks mentioned: BLUE, IMTX, ONTX
1 month ago - Benzinga

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) has entered into a license agreement with Innovet Italia SRL to develop US Food and Drug Administration-approved veterinary drugs for the treatment of ...

1 month ago - Proactive Investors

HUGE stock is on the move Wednesday after FSD Pharma announced a potentially lucrative move in the pet care market. Here's what to know.

1 month ago - InvestorPlace

TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces that it has entered into a license agreement (the “License Agreement”) with...

1 month ago - Business Wire

Toronto, Ontario--(Newsfile Corp. - March 8, 2021) - The group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) (the "Company" or "FSD") ...

2 months ago - Newsfile Corp

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will cont...

Other stocks mentioned: ACB, APHA, CGC, CRON, GNLN, HEXO, IIPR ...
2 months ago - Schaeffers Research

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) said it has entered into an equity sales agreement with A.G.P./Alliance Global Partners covering the sale of Class B subordinate voting shares of the company on ...

2 months ago - Proactive Investors

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that it has entered into an Equity Distribution Agreement dated February 11, 2021 (the ...

2 months ago - Business Wire

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will deve...

Other stocks mentioned: ACB, APHA, ARNA, IIPR, TLRY, XXII, YCBD
3 months ago - Schaeffers Research

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates. Corporate Update The Company continues to pursue its...

3 months ago - Business Wire

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (“FSD Pharma” or the “Company”) today announced that it will hold its annual meeting of shareholders (the “Meeting”) on June 29, 2021. ...

3 months ago - Business Wire

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced the dosing of the first patient in its Phase 2a clinical trial of FSD201 (ultramicron...

4 months ago - Business Wire

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in th...

Other stocks mentioned: ACB, ARNA, CGC, HEXO, KERN, OGI, SNDL ...
5 months ago - Schaeffers Research

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced its financial results for the third quarter ending September 30, 2020 and provided a ...

5 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDPharma--FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that, subject to court certification and other customary conditions, it ha...

6 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for the purchas...

6 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchase and sale...

6 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announced that the U.S. Food and Drug Administration (“FDA”) has authorized the initiatio...

7 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has submitted to the U.S.

8 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financial conditi...

9 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announces the closing of a previously announced agreement with investors for the purchase...

9 months ago - Business Wire

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc.

9 months ago - Newsfile Corp

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the pu...

9 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that it has notified Health Canada of the Company’s decision ...

9 months ago - Business Wire

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has entered into an Equity Distribution Agreement dated July 10, ...

9 months ago - Business Wire

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) -  FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, focused on developing, over time...

10 months ago - Newsfile Corp

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced favorable topline results from its Phase 1 randomized, double...

10 months ago - Business Wire

FSD Pharma Jumps On COVID-19 Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma

11 months ago - Seeking Alpha

Shares of FSD Pharma tripled Wednesday after the small-cap biotech company announced plans to study a potential coronavirus treatment. The drug is called ultramicronized PEA.

11 months ago - Investors Business Daily

FSD Pharma Inc. (NASDAQ: HUGE) shares absolutely exploded on Wednesday morning after the company received a key update from the U.S.

11 months ago - 24/7 Wall Street

Shares of FSD Pharma Inc (NASDAQ: HUGE) are advancing strongly Wednesday following an announcement regarding a potential COVID-19 drug.

11 months ago - Benzinga

FSD Pharma Inc (NASDAQ: HUGE) has netted itself more than $7.7 million through the sale of its 12% equity interest in Cannara Biotech Inc (OTC: LOVFF) to a consortium of that included entities controlle...

1 year ago - Benzinga

FSD Pharma Inc (CSE: HUGE) (OTC: FSDDF) said Monday that its Class B Subordinate Voting Shares have been accepted for listing on the NASDAQ Capital Market under the ticker "HUGE.

Other stocks mentioned: FSDDF
1 year ago - Benzinga

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) said Monday it has obtained approval for its Class B subordinate shares to list on the Nasdaq Capital Market.

Other stocks mentioned: FSDDF
1 year ago - Benzinga

About HUGE

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, ... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1998
CEO
Raza Bokhari
Employees
9
Stock Exchange
NASDAQ
Ticker Symbol
HUGE
Full Company Profile

Financial Performance

Financial numbers in millions CAD.
Financial Statements